Stay informed with the latest litigation news. Explore now

IP Verse

Artificial Nucleic Acid Molecules For Improved Protein Expression - EP4023755B1

EP4023755

CUREVAC
Application Number
EP21209125A
Filing Date
Dec 11, 2015
Status
Granted And Under Opposition
Mar 24, 2023
Grant Date
Apr 26, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3283059B1
EP4155409B1
EP4108769B1

Bibliography

The patent EP4023755B1 was granted to Curevac on Apr 26, 2023 following the initial filing on Dec 11, 2015 under the application number EP21209125A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOLEY UKJan 26, 2024ADMISSIBLE
PFIZERJan 26, 2024ADMISSIBLE
SANOFIJan 26, 2024ADMISSIBLE
BIONTECHDec 6, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents